Zobrazeno 1 - 10
of 138
pro vyhledávání: '"NN Tupitsyn"'
Autor:
T. M. Djumanazarov, Alexandra D. Palladina, N. A. Kupryshina, S. S. Gerasimov, NN Tupitsyn, A. K. Allakhverdiev, P. V. Kononetz, B. B. Akhmedov, Olga Chernysheva, O. P. Kolbatskaya, S. V. Chulkova
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 94-99 (2020)
Introduction.Detection of disseminated tumor cells (DTC) in solid tumors is an important component of the assessment of disease prognosis. Bone marrow damage is common. There is evidence indicating an important role for bone marrow lymphocyte subpopu
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 13, Iss 1, Pp 50-57 (2019)
Aim. To assess hematopoiesis in follicular lymphoma (FL) patients at different disease stages with different morphologic structures of tumor and bone marrow microenvironment. Materials & Methods. The trial included 152 FL patients treated from 2006 t
Autor:
I. N. Serebryakova, MA Shervashidze, N. A. Kupryshina, LYu Grivtsova, NN Tupitsyn, AV Popa, B. V. Kurdyukov, AD Palladina, O. A. Chernysheva, E. N. Sholokhova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 1, Pp 79-85 (2018)
Background. Minimal residual disease (MRD) is an independent prognostic factor in acute lymphoblastic leukemia (ALL) in children. The immunological assessment of MRD cell count is based on aberrant immunophenotype of tumor lymphoblasts. However, in t
Autor:
NN Tupitsyn, Liudmila Grivtsova
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S47-S48 (2021)
Objective: Mobilized peripheral hematopoietic stem cells are transplanted to cancer patients as support for high-dose chemotherapy. It is believed that the effectiveness of restoring all hematopoietic sprouts during HSC transplantation depends on the
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S25-(2021)
Objective Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia (AML) associated with poor prognosis for all patients except children with t(1;22) or Down syndrome. The frequency of complete remission in case of AMKL is c
Autor:
TR Panferova, Alla M. Kovrigina, GL Menkevich, II Matveeva, Timur Teimurazovich Valiev, LYu Grivtsova, AV Popa, EV Mikhailova, NN Tupitsyn, TL Ushakova, I. N. Serebryakova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 218-226 (2017)
The diagnosis of myeloid tumors is based on a complex approach and causes significant difficulties especially in young children. Morphologic, immunologic, cytogenetic, molecular and biologic data on myeloid sarcoma are presented based on the literatu
Autor:
I. N. Serebryakova, O. A. Beznos, AV Popa, LYu Grivtsova, NN Tupitsyn, OYu Baranova, MA Shervashidze, EA Osmanov
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 158-168 (2017)
Background & Aims. Evaluation of the minimal residual disease (MRD) at different stages of chemotherapy is one of key prognostic factors and a factor of stratification of patients into risk groups in acute lymphoblastic leukemia (ALL). The MRD detect
Autor:
A. V. Mozhenkova, NA Kupryshina, E N Sorokin, NN Tupitsyn, EA Osmanov, NV Kokosadze, Gayane Tumyan, OM Volodina, VA Doronin, MA Frenkel, N. A. Falaleeva
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 176-181 (2017)
It is the first description of a case of follicular lymphoma with a loss of CD20 antigen expression during the anti-tumor treatment including rituximab in the NN Blokhin Russian Cancer Research Center. The article discusses the tactics of further man
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 70-71 (2020)
Publikováno v:
Russian Journal of Biotherapy. 15:99-102
Background. Bone marrow is the mostfrequent metastatic site in follicular lymphoma, 40-70 % cases. It’s unfovourable prognostic role is stated in the index FLIPI-2 (Follicular Lymphoma International Prognostic Index-2). Objective. To study both pro